Abiopharma

News list

Director Antonellis Darcy 🟢 acquired 29.3K shares of Xperi Inc. (XPER) Transaction Date: Apr 17, 2026 | Filing ID: 046051

Full text

News bot April 21, 2026, 8:32 p.m.
🔍 Antonellis Darcy (Director)

Company: Xperi Inc. (XPER)

Report Date: 2026-04-17
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 29,320
Detailed Transactions and Holdings:
- Acquired 29,320 shares of Common Stock (Direct)
  Date: 2026-04-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 125,606.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: On April 17, 2026, the Reporting Person was granted 29,320 restricted stock units vesting in full on the earlier of (a) April 17, 2027, or (b) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant. Each restricted stock unit represents a contingent right to receive one share of Xperi Inc. common stock.